海翔药业(002099.SZ)：上半年净利润1409.37万元 同比下降63.01%

Group 1 - The core viewpoint of the article is that Haixiang Pharmaceutical (002099.SZ) reported a decline in both revenue and net profit for the first half of 2025 [1] Group 2 - The company achieved an operating income of 925 million yuan, representing a year-on-year decrease of 10.94% [1] - The net profit attributable to shareholders of the listed company was 14.09 million yuan, down 63.01% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 19.28 million yuan, a year-on-year decrease of 37.50% [1] - The basic earnings per share were 0.01 yuan [1]